X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE GSK PHARMA SUVEN LIFE/
GSK PHARMA
 
P/E (TTM) x 17.0 67.2 25.3% View Chart
P/BV x 3.5 13.5 25.9% View Chart
Dividend Yield % 0.7 1.1 61.1%  

Financials

 SUVEN LIFE   GSK PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
GSK PHARMA
Mar-18
SUVEN LIFE/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs2512,760 9.1%   
Low Rs1552,040 7.6%   
Sales per share (Unadj.) Rs49.1339.0 14.5%  
Earnings per share (Unadj.) Rs9.741.4 23.5%  
Cash flow per share (Unadj.) Rs11.445.9 24.8%  
Dividends per share (Unadj.) Rs1.5035.00 4.3%  
Dividend yield (eoy) %0.71.5 50.7%  
Book value per share (Unadj.) Rs60.3242.9 24.8%  
Shares outstanding (eoy) m127.2884.70 150.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.17.1 58.3%   
Avg P/E ratio x20.957.9 36.0%  
P/CF ratio (eoy) x17.852.3 34.1%  
Price / Book Value ratio x3.49.9 34.1%  
Dividend payout %15.484.5 18.3%   
Avg Mkt Cap Rs m25,825203,280 12.7%   
No. of employees `0001.1NA-   
Total wages/salary Rs m6135,234 11.7%   
Avg. sales/employee Rs Th5,832.6NM-  
Avg. wages/employee Rs Th571.5NM-  
Avg. net profit/employee Rs Th1,153.8NM-  
INCOME DATA
Net Sales Rs m6,25328,715 21.8%  
Other income Rs m233545 42.7%   
Total revenues Rs m6,48529,260 22.2%   
Gross profit Rs m1,9825,059 39.2%  
Depreciation Rs m213380 56.1%   
Interest Rs m462 2,315.0%   
Profit before tax Rs m1,9555,222 37.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0178 0.0%   
Tax Rs m7181,892 38.0%   
Profit after tax Rs m1,2373,508 35.3%  
Gross profit margin %31.717.6 179.9%  
Effective tax rate %36.736.2 101.4%   
Net profit margin %19.812.2 161.9%  
BALANCE SHEET DATA
Current assets Rs m5,62221,815 25.8%   
Current liabilities Rs m1,16815,999 7.3%   
Net working cap to sales %71.220.3 351.7%  
Current ratio x4.81.4 353.1%  
Inventory Days Days8164 128.0%  
Debtors Days Days3619 192.3%  
Net fixed assets Rs m3,32512,475 26.7%   
Share capital Rs m127847 15.0%   
"Free" reserves Rs m7,54719,726 38.3%   
Net worth Rs m7,67420,573 37.3%   
Long term debt Rs m146 231.7%   
Total assets Rs m9,13539,475 23.1%  
Interest coverage x43.22,612.0 1.7%   
Debt to equity ratio x00 621.1%  
Sales to assets ratio x0.70.7 94.1%   
Return on assets %14.08.9 158.0%  
Return on equity %16.117.1 94.5%  
Return on capital %26.026.2 99.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,066564 898.2%   
Fx outflow Rs m2,0017,429 26.9%   
Net fx Rs m3,065-6,865 -44.6%   
CASH FLOW
From Operations Rs m6994,728 14.8%  
From Investments Rs m-6-1,042 0.6%  
From Financial Activity Rs m-577-3,066 18.8%  
Net Cashflow Rs m116620 18.8%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 0.0 10.2 -  
FIIs % 0.0 23.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 15.4 237.0%  
Shareholders   37,287 102,036 36.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   SUN PHARMA  DR. REDDYS LAB  ABBOTT INDIA  FULFORD INDIA  MERCK LTD  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets End Lower; Metal Stocks Top Losers(Closing)

Indian share markets settled lower today led by a fall in the financial stocks after the rupee hit a record low of 70.32 per dollar.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

GSK PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 235.3% (Quarterly Result Update)

Jul 26, 2018 | Updated on Jul 26, 2018

For the quarter ended June 2018, GSK PHARMA has posted a net profit of Rs 886 m (up 235.3% YoY). Sales on the other hand came in at Rs 7 bn (up 21.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 16, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - GLENMARK PHARMA COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS